Treatment and intervention for opiate dependence in the United Kingdom: lessons from triumph and failure
| Autor: | Nicola J. Kalk, Eilish Gilvarry, Ed Day, Brian Kidd, J. Roy Robertson, John Strang, Michael Kelleher |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
Economic growth
DEATHS media_common.quotation_subject ENGLAND Psychological intervention 030508 substance abuse Social Sciences Opiate dependence Criminology Public administration 03 medical and health sciences Patient safety 0302 clinical medicine Acquired immunodeficiency syndrome (AIDS) Political science Intervention (counseling) medicine Drug policy METHADONE 030212 general & internal medicine media_common TAKE-HOME NALOXONE Harm reduction Government DRUG-USERS Addiction TREATMENT POLICY Abstinence HIV/aids medicine.disease GENERAL-PRACTITIONERS SCOTLAND Recovery agenda HEROIN OVERDOSE 0305 other medical science Criminology & Penology FOLLOW-UP Law Health care services |
| Zdroj: | Kalk, N J, Robertson, J R, Kidd, B, Day, E, Kelleher, M J, Gilvarry, E & Strang, J 2017, ' Treatment and Intervention for Opiate Dependence in the United Kingdom : Lessons from Triumph and Failure ', European Journal on Criminal Policy and Research, pp. 1-18 . https://doi.org/10.1007/s10610-017-9364-z Kalk, N J, Robertson, J R, Kidd, B, Day, E, Kelleher, M J, Gilvarry, E & Strang, J 2018, ' Treatment and Intervention for Opiate Dependence in the United Kingdom: Lessons from Triumph and Failure ', European Journal on Criminal Policy and Research, vol. 24, no. 2, pp. 183-200 . https://doi.org/10.1007/s10610-017-9364-z |
| DOI: | 10.1007/s10610-017-9364-z |
| Popis: | The history of opiate treatment in the United Kingdom (UK) since the early 1980s is a rich source of learning about the benefits and pitfalls of drug treatment policy. We present five possible lessons to be learnt about how factors outside the clinic, including government, charities and researchers can influence treatment and outcomes. First, do not let a crisis go to waste. The philosophical shift from abstinence to harm reduction in the 1980s, in response to an HIV outbreak in injecting users, facilitated expansion in addiction services and made a harm reduction approach more acceptable. Second, studies of drug-related deaths can lead to advances in care. By elucidating the pattern of mortality, and designing interventions to address the causes, researchers have improved patient safety in certain contexts, though significant investment in Scotland has not arrested rising mortality. Third, collection of longitudinal data and its use to inform clinical guidelines, as pursued from the mid-1990s, can form an enduring evidence base and shape policy, sometimes in unintended ways. Fourth, beware of the presentation of harm reduction and recovery as in conflict. At the least, this reduces patient choice, and at worst, it has caused some services to be redesigned in a manner that jeopardises patient safety. Fifth, the relationship between the third and state sectors must be carefully nurtured. In the UK, early collaboration has been replaced by competition, driven by changes in funding, to the detriment of service provision. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|